[Oncological aspects of hormonal contraception].
D001943:Breast Neoplasms / Q000139:chemically induced*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004714:Endometrial Hyperplasia / Q000139:chemically induced; D045166:Estradiol Congeners / Q000009:adverse effects; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D010053:Ovary / Q000187:drug effects; D011247:Pregnancy; D013329:Structure-Activity Relationship; D014594:Uterine Neoplasms / Q000139:chemically induced*
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D045166:Estradiol Congeners
Onkologicheskie aspekty gormonal'noĭ kontratseptsii.